Doç. Dr. İhsan SOLMAZ

1. The role of lipid-derived indices in patients with MASLD in Turkey: a nationwide, multicenter cross-sectional study

SOLMAZ İ., Kırık A., DEMİR İ., DİZDAR O. S., Gözel N., TAZEGÜL G., et al.

Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus)

2. Association Between Atherogenic Indices and the Triglyceride–Glucose Index in Individuals with Obesity

Alakuş Ö. F., Kılıç J., SOLMAZ İ.

Sakarya Medical Journal , cilt.16, sa.2, ss.276-284, 2026 (Scopus, TRDizin)

3. Uncoupling Systemic Inflammation from Body Mass Index: The Unseen Role of Visceral Adiposity and Metabolic Phenotypes—A Subgroup Analysis of the Nationwide OBREDI-TR Cohort

İşsever K., Oral A., Genç A. C., SOLMAZ İ., KOCA N., Topaloglu U. S., et al.

Journal of Clinical Medicine , cilt.15, sa.10, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Hidden Burden of Hypertension in Türkiye: A Multi-Center DAHUDER World Hypertension Day Study Reveals Gaps in Awareness, Adherence, and Control

SÜMBÜL H. E., SOLMAZ İ., Arac E., DEMİR İ., UYAR S., KONUR K., et al.

Journal of Clinical Medicine , cilt.15, sa.9, 2026 (SCI-Expanded, Scopus)

5. Clinical Utility of the Triglyceride–Glucose Index in Assessing Hepatic Steatosis Severity Within the MASLD Spectrum

Alakuş Ö. F., SOLMAZ İ., Kiliç J., Çiçek S.

Diagnostics , cilt.16, sa.6, 2026 (SCI-Expanded, Scopus)

6. The Impact of Body Mass Index and Nutritional Status on Cardiac Electrophysiological Balance Using ICEB and ICEBc: A Cross-Sectional Approach

Kayan F., Alakuş Ö. F., Elçiçek M., Soner S., Öztürk C., Güleken G., et al.

Journal of Cardiovascular Development and Disease , cilt.13, sa.3, 2026 (SCI-Expanded, Scopus)

7. Association of Fat and Muscle Mass With Overall Survival in Patients With Metastatic Prostate Cancer Treated With Enzalutamide, Abiraterone, and Docetaxel

SOLMAZ İ., KÖMEK H., Kayan F., Can C., Kaplan İ., Kiliç R., et al.

Clinical Genitourinary Cancer , cilt.24, sa.1, 2026 (SCI-Expanded, Scopus)

8. Red cell distribution width and mean platelet volume as mortality markers in patients with COVID-19: a retrospective cohort study

Kiliç J., Alakuş Ö. F., SOLMAZ İ.

Journal of Infection in Developing Countries , cilt.20, sa.2, ss.160-166, 2026 (SCI-Expanded, Scopus)

9. Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study

Kama Basci O., Oral A., Kirik A., Sen H., SOLMAZ İ., Topaloglu U. S., et al.

Diagnostics , cilt.16, sa.4, 2026 (SCI-Expanded, Scopus)

10. Hepatic fibrosis severity assessed by FIB-4 index is independently associated with reduced kidney function in patients with metabolic dysfunction-associated steatotic liver disease: a nationwide multicenter study from Türkiye

SÜMBÜL H. E., Kirik A., Yaylaci S., Oral A., Serin S. O., Issever K., et al.

Hepatology International , 2026 (SCI-Expanded, Scopus)

11. Beyond awareness: analyzing the incomplete integration and barriers to POCUS implementation: a nationwide study

TAZEGÜL G., GÜVEN A. T., Serin S. O., Yalçın N., IRMAK KAYA Z., KONUR K., et al.

Internal and Emergency Medicine , 2026 (SCI-Expanded, Scopus)

12. Predictive value of blood gas parameters and hematologic indices on survival in critically ill sepsis patients

Toprak N., Kaya B., Kiliç J., COŞKUNER M. A., KÖKER G., Alakuş Ö. F., et al.

Journal of Infection in Developing Countries , cilt.19, sa.12, ss.1809-1816, 2025 (SCI-Expanded, Scopus)

13. Reliability and validity of the Turkish version of the trust in physician scale in community-dwelling older adults

BAŞGÖZ B. B., ÇETİN M., KÖKER G., SOLMAZ İ., Yıldırım M. S., NAHARCI M. İ.

BMC Geriatrics , cilt.25, sa.1, 2025 (SCI-Expanded, SSCI, Scopus)

14. Predictive value of the FIB-4 index, APRI, ALBI score, and GPR for overall survival in treatment-naïve metastatic colorectal cancer patients

Yıldırım M. S., Güzel Y., Can C., Kaplan İ., Şenses V., SOLMAZ İ., et al.

BMC Gastroenterology , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

15. Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study)

Kirik A., SÜMBÜL H. E., KOCA N., PAŞALI KİLİT T., Demiral Sezer S., Binnetoglu E., et al.

Journal of Clinical Medicine , cilt.14, sa.19, 2025 (SCI-Expanded, Scopus)

16. Effect of Orlistat Treatment on Visceral Adiposity Index (VAI) in Obese Patients

SOLMAZ İ., Kılıç J., Alakuş Ö. F.

Sakarya Medical Journal , cilt.15, sa.2, ss.128-134, 2025 (Scopus, TRDizin)

17. Obesity-Related Disorders in Türkiye: A Multi Center, Retrospective, Cross-Sectional Analysis from the OBREDI-TR Study

Oral A., SOLMAZ İ., KOCA N., Topaloglu U. S., DEMİR İ., Dundar A., et al.

Journal of Clinical Medicine , cilt.14, sa.8, 2025 (SCI-Expanded, Scopus)

18. Healthcare-associated infections in patients with COVID-19: is it different from the pre-pandemic period?

SOLMAZ İ., Kavak Ş., DOĞAN ARAÇ S., Akelma H., BAŞGÖZ B. B., Koyun S., et al.

Journal of Infection in Developing Countries , cilt.18, sa.9, 2024 (SCI-Expanded, Scopus)

19. Metabolic Dysfu nctio n-As socia ted Fatty Liver Disease and Fibrosis Status in Patients with Type 2 Diabetes Treated at Internal Medicine Clinics: Türkiye DAHUDER Awareness of Fatty Liver Disease (TR-DAFLD) Study

ŞAHİNTÜRK Y., KÖKER G., KOCA N., SÜMBÜL H. E., DEMİR İ., KESKİN H., et al.

Turkish Journal of Gastroenterology , cilt.36, sa.8, ss.643-650, 2024 (SCI-Expanded, Scopus, TRDizin)

20. Comparison of scoring systems: SOFA, APACHE-II, LODS, MODS, and SAPS-II in critically ill elderly sepsis patients

Tekin B., Kiliç J., TAŞKIN G., SOLMAZ İ., TEZEL O., BAŞGÖZ B. B.

Journal of Infection in Developing Countries , cilt.18, sa.1, ss.122-130, 2024 (SCI-Expanded, Scopus)

21. ABO blood groups in COVID-19 patients; Cross-sectional study

SOLMAZ İ., DOĞAN ARAÇ S.

International Journal of Clinical Practice , cilt.75, sa.4, 2021 (SCI-Expanded, Scopus)

Doç. Dr. İhsan SOLMAZ

Yayınlar & Eserler

1. The role of lipid-derived indices in patients with MASLD in Turkey: a nationwide, multicenter cross-sectional study

2. Association Between Atherogenic Indices and the Triglyceride–Glucose Index in Individuals with Obesity

3. Uncoupling Systemic Inflammation from Body Mass Index: The Unseen Role of Visceral Adiposity and Metabolic Phenotypes—A Subgroup Analysis of the Nationwide OBREDI-TR Cohort

4. Hidden Burden of Hypertension in Türkiye: A Multi-Center DAHUDER World Hypertension Day Study Reveals Gaps in Awareness, Adherence, and Control

5. Clinical Utility of the Triglyceride–Glucose Index in Assessing Hepatic Steatosis Severity Within the MASLD Spectrum

6. The Impact of Body Mass Index and Nutritional Status on Cardiac Electrophysiological Balance Using ICEB and ICEBc: A Cross-Sectional Approach

7. Association of Fat and Muscle Mass With Overall Survival in Patients With Metastatic Prostate Cancer Treated With Enzalutamide, Abiraterone, and Docetaxel

8. Red cell distribution width and mean platelet volume as mortality markers in patients with COVID-19: a retrospective cohort study

9. Discordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study

10. Hepatic fibrosis severity assessed by FIB-4 index is independently associated with reduced kidney function in patients with metabolic dysfunction-associated steatotic liver disease: a nationwide multicenter study from Türkiye

11. Beyond awareness: analyzing the incomplete integration and barriers to POCUS implementation: a nationwide study

12. Predictive value of blood gas parameters and hematologic indices on survival in critically ill sepsis patients

13. Reliability and validity of the Turkish version of the trust in physician scale in community-dwelling older adults

14. Predictive value of the FIB-4 index, APRI, ALBI score, and GPR for overall survival in treatment-naïve metastatic colorectal cancer patients

15. Prevalence of MASLD and Fibrosis Risk in Turkish Adults with Cardiometabolic Risk Factors: A Nationwide Multicenter Study (DAHUDER MASLD Study)

16. Effect of Orlistat Treatment on Visceral Adiposity Index (VAI) in Obese Patients

17. Obesity-Related Disorders in Türkiye: A Multi Center, Retrospective, Cross-Sectional Analysis from the OBREDI-TR Study

18. Healthcare-associated infections in patients with COVID-19: is it different from the pre-pandemic period?

19. Metabolic Dysfu nctio n-As socia ted Fatty Liver Disease and Fibrosis Status in Patients with Type 2 Diabetes Treated at Internal Medicine Clinics: Türkiye DAHUDER Awareness of Fatty Liver Disease (TR-DAFLD) Study

20. Comparison of scoring systems: SOFA, APACHE-II, LODS, MODS, and SAPS-II in critically ill elderly sepsis patients

21. ABO blood groups in COVID-19 patients; Cross-sectional study

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim